Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01610622 · ClinicalTrials.gov registry record

Estimation of Cardiac Output in Neonatal ICU Using an Ultrasound Dilution Technique

A clinical trial, sponsored by Transonic Systems.

Completed
Registry status
7
Enrollment target

NCT01610622: Completed study, sponsored by Transonic Systems.

NCT01610622 is a clinical trial that has completed, run by Transonic Systems. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01610622 has completed, sponsored by Transonic Systems.

COMPLETED
Registry status
7 participants
Enrollment target

Study Summary

Presently there is no apparatus, clinically available, for routine determination of cardiac output (CO) in children. The goal of this research is to develop new technology that will help determine CO in neonates.

Interventions

  • DEVICE COstatus cardiac output measurement with isotonic saline

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2012-03
Est. Completion 2013-05
Transonic Systems

12 total trials

What the finished NCT01610622 record still lists

NCT01610622 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which COstatus cardiac output measurement with isotonic saline is the first listed.

NCT01610622 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01610622 about?

NCT01610622 is a clinical study titled "Estimation of Cardiac Output in Neonatal ICU Using an Ultrasound Dilution Technique". Presently there is no apparatus, clinically available, for routine determination of cardiac output (CO) in children. The goal of this research is to develop new technology that will help determine CO in neonates.

What is the current status of trial NCT01610622?

This trial is currently completed. The enrollment target is 7 participants. The study started on 2012-03. Estimated completion is 2013-05.

What interventions are being tested in trial NCT01610622?

The interventions under investigation include: COstatus cardiac output measurement with isotonic saline (DEVICE).

Who is sponsoring clinical trial NCT01610622?

This trial is sponsored by Transonic Systems, which has 12 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01610622, the US trial registry maintained by the National Library of Medicine. NCT01610622 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.